Not applicableStudy completedNCT02384395
What this trial is testing
Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
Who this might be right for
HIVAcute HIV Infection
University of North Carolina, Chapel Hill 40